102 related articles for article (PubMed ID: 12111397)
1. Structure-cytotoxicity relationships for a series of HEPT derivatives.
Bazoui H; Zahouily M; Sebti S; Boulajaaj S; Zakarya D
J Mol Model; 2002 Jan; 8(1):1-7. PubMed ID: 12111397
[TBL] [Abstract][Full Text] [Related]
2. QSAR for anti-HIV activity of HEPT derivatives.
Bazoui H; Zahouily M; Boulajaaj S; Sebti S; Zakarya D
SAR QSAR Environ Res; 2002 Oct; 13(6):567-77. PubMed ID: 12479372
[TBL] [Abstract][Full Text] [Related]
3. Neural networks: Accurate nonlinear QSAR model for HEPT derivatives.
Douali L; Villemin D; Cherqaoui D
J Chem Inf Comput Sci; 2003; 43(4):1200-7. PubMed ID: 12870912
[TBL] [Abstract][Full Text] [Related]
4. A 3D QSAR study of a series of HEPT analogues: the influence of conformational mobility on HIV-1 reverse transcriptase inhibition.
Kireev DB; Chrétien JR; Grierson DS; Monneret C
J Med Chem; 1997 Dec; 40(26):4257-64. PubMed ID: 9435895
[TBL] [Abstract][Full Text] [Related]
5. Artificial neural networks: non-linear QSAR studies of HEPT derivatives as HIV-1 reverse transcriptase inhibitors.
Douali L; Villemin D; Zyad A; Cherqaoui D
Mol Divers; 2004; 8(1):1-8. PubMed ID: 14964783
[TBL] [Abstract][Full Text] [Related]
6. QSAR based on multiple linear regression and PLS methods for the anti-HIV activity of a large group of HEPT derivatives.
Luco JM; Ferretti FH
J Chem Inf Comput Sci; 1997; 37(2):392-401. PubMed ID: 9090857
[TBL] [Abstract][Full Text] [Related]
7. Use of artificial neural networks in a QSAR study of anti-HIV activity for a large group of HEPT derivatives.
Jalali-Heravi M; Parastar F
J Chem Inf Comput Sci; 2000; 40(1):147-54. PubMed ID: 10661561
[TBL] [Abstract][Full Text] [Related]
8. A novel simple QSAR model for the prediction of anti-HIV activity using multiple linear regression analysis.
Afantitis A; Melagraki G; Sarimveis H; Koutentis PA; Markopoulos J; Igglessi-Markopoulou O
Mol Divers; 2006 Aug; 10(3):405-14. PubMed ID: 16896545
[TBL] [Abstract][Full Text] [Related]
9. Application of ant colony optimization in development of models for prediction of anti-HIV-1 activity of HEPT derivatives.
Zare-Shahabadi V; Abbasitabar F
J Comput Chem; 2010 Sep; 31(12):2354-62. PubMed ID: 20575016
[TBL] [Abstract][Full Text] [Related]
10. 4D-QSAR study of HEPT derivatives by electron conformational-genetic algorithm method.
Akyüz L; Sarıpınar E; Kaya E; Yanmaz E
SAR QSAR Environ Res; 2012 Jul; 23(5-6):409-33. PubMed ID: 22452710
[TBL] [Abstract][Full Text] [Related]
11. QSAR study on some anti-HIV HEPT analogues using physicochemical and topological parameters.
Gayen S; Debnath B; Samanta S; Jha T
Bioorg Med Chem; 2004 Mar; 12(6):1493-503. PubMed ID: 15018923
[TBL] [Abstract][Full Text] [Related]
12. Conformational study of the HIV-1 reverse transcriptase inhibitor 1-[(2-hydroxyethoxy)methyl]-6-(phenylthio)thymine (HEPT).
Lawtrakul L; Hannongbua S; Beyer A; Wolschann P
Biol Chem; 1999 Feb; 380(2):265-7. PubMed ID: 10195434
[TBL] [Abstract][Full Text] [Related]
13. Comparative QSAR based on neural networks for the anti-HIV activity of HEPT derivatives.
Douali L; Villemin D; Cherqaoui D
Curr Pharm Des; 2003; 9(22):1817-26. PubMed ID: 12871199
[TBL] [Abstract][Full Text] [Related]
14. Linear and non-linear quantitative structure-activity relationship models on indole substitution patterns as inhibitors of HIV-1 attachment.
Nirouei M; Ghasemi G; Abdolmaleki P; Tavakoli A; Shariati S
Indian J Biochem Biophys; 2012 Jun; 49(3):202-10. PubMed ID: 22803336
[TBL] [Abstract][Full Text] [Related]
15. Quantitative structure-activity relationship study on the anti-HIV-1 activity of novel 6-naphthylthio HEPT analogs.
Riahi S; Pourbasheer E; Dinarvand R; Ganjali MR; Norouzi P
Chem Biol Drug Des; 2009 Aug; 74(2):165-72. PubMed ID: 19549086
[TBL] [Abstract][Full Text] [Related]
16. Prediction of cytotoxicity data (CC(50)) of anti-HIV 5-phenyl-1-phenylamino-1H-imidazole derivatives by artificial neural network trained with Levenberg-Marquardt algorithm.
Arab Chamjangali M; Beglari M; Bagherian G
J Mol Graph Model; 2007 Jul; 26(1):360-7. PubMed ID: 17350867
[TBL] [Abstract][Full Text] [Related]
17. Evolutionary optimization, backpropagation, and data preparation issues in QSAR modeling of HIV inhibition by HEPT derivatives.
Weekes D; Fogel GB
Biosystems; 2003 Nov; 72(1-2):149-58. PubMed ID: 14642664
[TBL] [Abstract][Full Text] [Related]
18. Predictive QSAR modeling of HIV reverse transcriptase inhibitor TIBO derivatives.
Mandal AS; Roy K
Eur J Med Chem; 2009 Apr; 44(4):1509-24. PubMed ID: 18760864
[TBL] [Abstract][Full Text] [Related]
19. Anti-HIV activity of HEPT, TIBO, and cyclic urea derivatives: structure-property studies, focused combinatorial library generation, and hits selection using substructural molecular fragments method.
Solov'ev VP; Varnek A
J Chem Inf Comput Sci; 2003; 43(5):1703-19. PubMed ID: 14502505
[TBL] [Abstract][Full Text] [Related]
20. N1-Alkyl pyrimidinediones as non-nucleoside inhibitors of HIV-1 reverse transcriptase.
Mitchell ML; Son JC; Guo H; Im YA; Cho EJ; Wang J; Hayes J; Wang M; Paul A; Lansdon EB; Chen JM; Graupe D; Rhodes G; He GX; Geleziunas R; Xu L; Kim CU
Bioorg Med Chem Lett; 2010 Mar; 20(5):1589-92. PubMed ID: 20138513
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]